Insights

Ideas on regulatory, quality and launch decisions

Short notes, grounded in field experience, on how to reach the market with less rework and better-founded decisions.

Why medical product business cases tend to be too optimistic

The invisible mistake that inflates medical product business cases: sampling regulatory delays without connecting them to cash flow. How to fix it.

This is how we work the decision: financial feasibility, quality design and entry strategy, in a single model.